This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Gerresheimer, Bormioli Pharma deal gets conditional approval in Austria

( November 20, 2024, 09:25 GMT | Official Statement) -- MLex Summary: Gerresheimer, a packaging maker for drugs and cosmetics, has received approval for its plans to acquire control of rival Bormioli Pharma, but subject to conditions, the Austrian competition authority has said. The deal would have led to high combined market shares for primary packaging made of soda-lime glass for the pharmaceutical industry.  To win approval, the companies agreed to take measures to ensure that a competitor, or remedy taker, can successfully access that market.Statement follows in German. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login